Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

the FDA and the first approved treatment for all five subtypes of MDS.

The combination of azacitidine (Vidaza) and valproic acid is safe and active in advanced solid tumors - A.O. Soriano; Abstract #3547; June 2, 2007; 2-6pm; McCormick Place Convention Center, S102a

Results were reported this afternoon from a Phase I study of Azacitidine, a DNA hypomethylating agent, in combination with valproic acid, an HDAC inhibitor, in patients with advanced solid tumors. The study, which included patients with advanced forms of 10 different solid tumors, evaluated the safety and activity of the two compounds in combination.

Of 55 evaluable patients, 14 patients, or 25 percent, were observed to experience stable disease in a variety of advanced solid tumors. The duration of the patients' stable disease was four to 12 months, with a median of six months.

These data show that the combination of the two compounds was safe and active in patients with advanced solid tumors The data also indicated that the maximum tolerated dose of azacitidine when used in the combination was 75 mg/m2. Significant global DNA hypomethylation and histone acetylation were demonstrated.

Data Presented Saturday, June 2

Phase I/II study of a novel oral isotype-selective histone deacetylase (HDAC) inhibitor MGCD0103 in combination with Azacitidine in patients (pts) with high-risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML) - G. Garcia-Manero, MD, MD Anderson Cancer Center; Abstract #7062; June 2, 2007; 8:00-12:00 pm; McCormick Convention Center, S Hall A2

The combination of 5-azacytidine and valproic acid is safe and active in advanced solid tumors - A.O. Soriano, MD Anderson Cancer Center; Abstract #3547; June 2, 2007; 2:00-6:00pm; McCormick Place Convention Center, S102a

Tolerability and hematologic improvement assessed using three alternative dosing schedules of azacitidine (Vidaza) in patients with MDS - R. Lyons, US Oncology;
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:5/21/2015)... , May 21, 2015 The Pharmaceutical ... regarding the Medicare Part D offsets included in ... initiative: "If the 21st Century Cures initiative ... America,s premier health program – Medicare – then ... yield down the road. "Leveraging payments ...
(Date:5/21/2015)... , May 21, 2015  Today, ... physicians who prescribe biologics – Alliance for ... American College of Rheumatology, Biologics Prescribers Collaborative, ... Organizations, Endocrine Society, and North American Society ... sent a letter to U.S. Food and ...
(Date:5/21/2015)... Research and Markets( http://www.researchandmarkets.com/research/pw67sw/xray_market ) has announced the addition of ... Trends and Forecast 2014 - 2022" report to their ... the largest share of 34.6% of the global X-ray market ... and Europe . North America ... Canada that have a large number ...
Breaking Medicine Technology:Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 2Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 3Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 4X-Ray Market: Global Industry Analysis 2014 - 2022 2
... MORRISTOWN, N.J. , July 12 ... confirmed that its subsidiary, Watson Laboratories, Inc., filed an ... and Drug Administration (FDA) seeking approval to market sevelamer ...  Watson,s sevelamer carbonate for oral suspension product is the ...
... BETHESDA, Md. , July 12 The Hanger ... generous donation of $75,000 from Grapes for Humanity/US, ... dollars in support of landmine survivors and innocent victims of ... used by the Hanger Ivan R. Sabel Foundation to continue ...
Cached Medicine Technology:Watson Confirms Renvela® for Oral Suspension Patent Challenge 2Watson Confirms Renvela® for Oral Suspension Patent Challenge 3Hanger Ivan R. Sabel Foundation to Receive $75,000 Donation Towards Charitable Prosthetic Efforts in Haiti from Grapes for Humanity/US 2
(Date:5/21/2015)... Charlotte, NC (PRWEB) May 21, 2015 ... regulates the surface temperature of each side of the ... With ChiliPad, users on either side of the bed ... all night, helping them fall asleep faster and stay ... patented system with water to regulate the temperature which ...
(Date:5/21/2015)... New York, New York (PRWEB) May 21, 2015 ... of The Atmananda Yoga Studio and Sequence, is ... popular Atmananda Yoga Mat™, which was previously available for ... The Atmananda Yoga Mat™ unique is that it's ... help prevent serious joint injuries and muscle strains, ...
(Date:5/21/2015)... Mich. (PRWEB) May 21, 2015 Many ... opposite effect on those with celiac disease according to ... than half of the probiotics tested in the study ... foods and dietary supplements and cause gastrointestinal inflammation for ... Companies aiming to gain consumer trust in gluten-free claims ...
(Date:5/21/2015)... Neogenis Labs , a world leader ... been named to the 2015 Austin A-List by the Austin ... by Southwest Interactive. , The A-List companies , selected ... nominations, were officially revealed and named to the annual Austin ... ACL-Live. The 12 honorees for 2015 were named in three ...
(Date:5/21/2015)... New York (PRWEB) May 21, 2015 ... Roslin, MD, Director of Bariatric Surgery at Northern Westchester ... bariatric surgery procedure called Stomach Intestinal Pylorus-Sparing Surgery ... modification to the duodenal switch procedure and benefits patients ... , The Stomach Intestinal Pylorus-Sparing Surgery technique was broadcast ...
Breaking Medicine News(10 mins):Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 2Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 3Health News:NY's Atmananda Yoga Studio Launches Its Patented "Alignment" Yoga Mat for Public Sale 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4Health News:Neogenis® Labs Named to 2015 Austin A-List Most Promising Startups 2Health News:Neogenis® Labs Named to 2015 Austin A-List Most Promising Startups 3Health News:Northern Westchester Hospital Surgeon Mitchell Roslin, MD Conducts International Broadcast of Bariatric Surgery Technique 2Health News:Northern Westchester Hospital Surgeon Mitchell Roslin, MD Conducts International Broadcast of Bariatric Surgery Technique 3
... , VISTA, Calif., Aug. 6 Nutritional ... a new marketing campaign touting its flagship, patented nutritional supplement product ... , , The new marketing campaign takes a ... drink enhancer by using a caricature of Albert Einstein at a ...
... , , OLDSMAR, Fla., ... of the largest and most established leaders in stem cell innovation, ... in menstrual blood (known as MenSCs) during the Fourth China Medical ... vitro study show that MenSCs proliferate rapidly and have significant potential ...
... , ( ) , , , ... N.J., Aug. 6 Smart Balance, Inc. (Nasdaq: SMBL ) today announced its ... of $58.2 million, an increase of 21.2% versus year ago, and earnings per share of ... The second quarter net sales increase versus 2008 was due to a 13% ...
... U.S. adults unaware there is no cure, survey finds , ... U.S. adults mistakenly believe that daily medicine can be taken ... that found a widespread lack of knowledge and awareness about ... of 2,148 adults also found that nearly half of respondents ...
... are choosing it for their animal companions , THURSDAY, Aug. ... anymore, as more animal owners are making that choice for ... , For nearly 20 years, a handful of veterinarians has ... kidney failure, to die peacefully at home, not in a ...
... , NASHVILLE, Tenn. and GLEN ... find that 76 percent of surveyed pharmacy directors say ... will have only one preferred biologic for all immune ... ulcerative colitis. According to the new Formulary Forum report ...
Cached Medicine News:Health News:Global Health Trax, Inc. Announces New Marketing Campaign for Oxygen Elements Max Product 2Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 2Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 3Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 4Health News:Smart Balance Announces 2009 Second Quarter Results 2Health News:Smart Balance Announces 2009 Second Quarter Results 3Health News:Smart Balance Announces 2009 Second Quarter Results 4Health News:Smart Balance Announces 2009 Second Quarter Results 5Health News:Smart Balance Announces 2009 Second Quarter Results 6Health News:Smart Balance Announces 2009 Second Quarter Results 7Health News:Smart Balance Announces 2009 Second Quarter Results 8Health News:Smart Balance Announces 2009 Second Quarter Results 9Health News:Smart Balance Announces 2009 Second Quarter Results 10Health News:Food Allergy Facts Need More Focus 2Health News:Hospice Care Eases the End for Loyal Pets 2Health News:Hospice Care Eases the End for Loyal Pets 3Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 2Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 3
... for Cardiology is the first digital solution ... modalities both within and outside cardiology. From ... the archival solutions, Agfas combined expertise in ... and their customers to work the way ...
Full Digital Ultrasound System...
... Nemio is engineered with the latest technologies ... enhance your clinical insight. These advancements increase ... crisp images that improve visualization of even ... connectivity, you can speed information delivery and ...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Medicine Products: